Back

PCSK9 inhibition: new insights

1 September 2024 (11:00 - 11:12)
Organised by: Logo
Congress Presentation Part of: Targeting lipids above and beyond statins: key new players Lipid-Lowering Agents ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Professor Lorenz Raber

Swiss Cardiovascular Center, Bern (Switzerland)

4 More presentations in this session

Presentation thumbnail
Strategies to inhibit Lp(a)
Professor F. Kronenberg (Innsbruck, AT)
Slides Video
Presentation thumbnail
Targeting triglycerides: is it worth it? lessons from recent trials
Associate Professor G. Liuzzo (Rome, IT)
Slides Video
Presentation thumbnail
Additional cholesterol synthesis inhibition, CETP inhibitors, and cholesterol-efflux enhancer therapies
Professor U. Landmesser (Berlin, DE)
Slides Video
Presentation thumbnail
Targeting lipids above and beyond statins: key new players - discussion
Video

Access the full session

Session thumbnail
Targeting lipids above and beyond statins: key new players
Video

The Event

Event poster

ESC Congress 2024

1 September 2024 11:00 CET
You may be interested in
thumbnail
Congress Presentation
What about long-term prevention?
thumbnail
Congress Presentation
PCSK9i: expanding benefits across the spectrum of cardiovascular disease
thumbnail
Congress Session
Late-breaking science on pharmacology

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources